Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
2005-3-9
pubmed:abstractText
in acromegaly, the criteria for the cure of the disease after neurosurgery have become tighter and tighter. In contrast, the evaluation of control of disease activity during medical treatment is based upon the normalisation of IGF-I levels and epidemiological criteria, i.e. lessening GH (assessed by RIA) to levels reported to normalise increased mortality. The aim of this study was to evaluate GH and IGF-I suppression during prolonged SS analogues (SA) treatment. The concordance between "safe" GH and normalised IGF-I levels during SA was also assessed, according to gender and gonadal status.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0391-4097
pubmed:author
pubmed:issnType
Print
pubmed:volume
27
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1040-7
pubmed:meshHeading
pubmed-meshheading:15754736-Acromegaly, pubmed-meshheading:15754736-Adult, pubmed-meshheading:15754736-Aged, pubmed-meshheading:15754736-Aged, 80 and over, pubmed-meshheading:15754736-Biological Markers, pubmed-meshheading:15754736-Cohort Studies, pubmed-meshheading:15754736-Endpoint Determination, pubmed-meshheading:15754736-Female, pubmed-meshheading:15754736-Human Growth Hormone, pubmed-meshheading:15754736-Humans, pubmed-meshheading:15754736-Insulin-Like Growth Factor I, pubmed-meshheading:15754736-Male, pubmed-meshheading:15754736-Middle Aged, pubmed-meshheading:15754736-Postmenopause, pubmed-meshheading:15754736-Prognosis, pubmed-meshheading:15754736-Retrospective Studies, pubmed-meshheading:15754736-Sensitivity and Specificity, pubmed-meshheading:15754736-Sex Factors, pubmed-meshheading:15754736-Somatostatin
pubmed:year
2004
pubmed:articleTitle
Treatment of acromegaly with SS analogues: should GH and IGF-I target levels be lowered to assert a tight control of the disease?
pubmed:affiliation
Division of Endocrinology, Niguarda Hospital, Milan, Italy. renatocozzi@tiscali.it
pubmed:publicationType
Journal Article, Clinical Trial, Multicenter Study